ARTICLE | Company News
Inspire, Faes deal
November 6, 2006 8:00 AM UTC
FAE granted ISPH an exclusive license in the U.S. and Canada to develop and commercialize oral bilastine to treat or prevent rhinitis, as well as an exclusive license to the ocular formulation in var...